Get the StoQuant digest — free
Free StoQuant digest by email. No account needed.
See today's research picks.
ATAI vs NKTR — Stock Comparison
Compare ATAI and NKTR side-by-side on StoQuant: ATAI Q-Score 50 vs NKTR 22; analyst signal 18 vs 74. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.
Side-by-side snapshot
- ATAI — Atai Beckley N.V · Health Care · market cap $2.73B · Q-Score verdict Unrated (50.0) · analyst signal 18/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: technicals 73/100, analyst consensus 0/100. Full ATAI research.
- NKTR — Nektar Therapeutics · Health Care · market cap $1.07B · Q-Score verdict Strong Sell (22.0, grade F) · analyst signal 74/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: competitive moat 86/100, analyst consensus 68/100 · weakest signals: technicals 3/100. Full NKTR research.
What you can compare
- Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
- Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
- Insider activity: Cluster scores and recent Form 4 buying.
- Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
- Strategic edges: Competitive moat and durable advantage analysis.
- Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
- Macro context: Market regime and sector rotation alignment.
Deep dive: ATAI research · NKTR research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →
Register founding interest — Pro $29/mo or Power $79/mo
Paid plans aren’t for sale yet. Leave your email to lock founding pricing (Pro $29, Power $79); we’ll reach out personally.